PeptidePedia The community reference

Special:RecentChanges

Change log·6,798 revisions·page 51 of 68

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 6,798 changes are logged in total.

6,798Logged changes
575Bot edits
167Page creations
256Active editors

13 January 2025

  1. (diff | hist) 11:32 Peptide content 4,810 +716 Chromatokid (talk | contribs) clarify that mass spectrometry confirms identity, not purity [rollback]
  2. (diff | hist) 11:02 Incretin effect 5,397 +218 Chromatokid (talk | contribs) ce per PP:MOS [rollback]
  3. (diff | hist) 09:45 Beyond-use date 8,887 +1,138 LyophilLena (talk | contribs) space between number and unit per PP:MOS [rollback]
  4. (diff | hist) 08:46 Global access disparity 1,977 ±0 OffLabelOdile (talk | contribs) clarify that the figures are for one country only [rollback]
  5. (diff | hist) 05:15 Vial 16,052 +509 ResinRhoswen (talk | contribs) add the data-logger point: an unlogged shipment has no excursion record [rollback]
  6. (diff | hist) m 02:20 Gastric emptying 4,636 +660 GsCouplingGil (talk | contribs) add the citation for the co-secretion finding [rollback]

12 January 2025

  1. (diff | hist) 20:13 Test report forgery 3,609 +700 NAION_Noel (talk | contribs) add the turnaround time the service publishes [rollback]
  2. (diff | hist) 19:49 International nonproprietary name 2,755 ±0 OralSemaOswin (talk | contribs) the half-life in the lead was the terminal figure; label it as such [rollback]
  3. (diff | hist) m 19:24 Contraindications of incretin therapy 2,653 ±0 PuffRemoverPax (talk | contribs) add the note that titration exists partly to manage these effects [rollback]
  4. (diff | hist) m 09:25 Reference standard 3,767 ±0 Chromatokid (talk | contribs) convert a hard-coded date to the house format [rollback]
  5. (diff | hist) 03:13 Peptide harm reduction 2,785 +33 DrTitration (talk | contribs) add category for pricing [rollback]
  6. (diff | hist) m b 01:47 Arcuate nucleus 3,773 +36 StubSorterBot (talk | contribs) bot: sort category members [rollback]

11 January 2025

  1. (diff | hist) 22:00 TRIUMPH trial programme 3,396 +559 NNT_Nerys (talk | contribs) state the analysis population: intention-to-treat or per-protocol [rollback]
  2. (diff | hist) m b 17:51 Trial data comparison 1,546 ±0 CiteBot (talk | contribs) bot: normalise citation format [rollback]
  3. (diff | hist) m b 13:04 Dose escalation schedule 2,870 ±0 CategoryBot (talk | contribs) bot: repair redlinked category [rollback]
  4. (diff | hist) m 12:00 Cagrilintide 3,147 +177 ConsensusConal (talk | contribs) add the excipient list from the labelling [rollback]
  5. (diff | hist) 10:27 Purity claim inflation 3,067 ±0 Chromatokid (talk | contribs) expand §What a purity figure does establish [rollback]
  6. (diff | hist) 10:26 Talk:Sangon Biotech 1,033 +75 ScopeSeverin (talk | contribs) /* Scope: is this a peptide supplier article at all? */ reply
  7. (diff | hist) 06:18 Melanotan II 2,703 +192 TriumphThad (talk | contribs) add the stability data with the storage condition it was measured at [rollback]
  8. (diff | hist) m 01:24 List of GLP-1 receptor agonists 3,023 +157 Chromatokid (talk | contribs) add see-also entries for the four articles that link here [rollback]
  9. (diff | hist) m 00:35 Dual incretin agonist 4,587 +16 IcodecIndra (talk | contribs) add a hatnote pointing at the analogue with the similar name [rollback]

10 January 2025

  1. (diff | hist) 23:12 Sarcopenia 2,319 +29 CRP_Cormac (talk | contribs) expand §Definition and assessment [rollback]
  2. (diff | hist) 20:06 VendorInvestigate 3,483 +43 LeanMassLars (talk | contribs) clarify that a signature on a certificate is a release, not a verification [rollback]
  3. (diff | hist) 18:12 Liquid chromatography-mass spectrometry 3,315 +673 NauseaNoor (talk | contribs) clarify the difference between related substances and total impurities [rollback]
  4. (diff | hist) m 13:24 Glucose-dependent insulinotropic polypeptide 6,231 ±0 IncretinIvo (talk | contribs) correct the direction of the effect on gastric emptying [rollback]
  5. (diff | hist) 11:04 Reconstitution of lyophilised peptides 4,173 +471 SharpsSukhi (talk | contribs) expand §Concentration arithmetic [rollback]
  6. (diff | hist) 10:57 Third-party testing 5,061 ±0 UnderfillUna (talk | contribs) state that the sample was not drawn blind, so it represents the vial and not the lot [rollback]
  7. (diff | hist) 09:36 Peptide supply chain 4,143 +131 ColdChainCleo (talk | contribs) ce, tighten prose [rollback]
  8. (diff | hist) m b 07:23 Orforglipron 3,337 +434 CategoryBot (talk | contribs) bot: expand DOI to full citation [rollback]
  9. (diff | hist) 02:00 Satiety signalling 4,078 +104 ReceptorRhoda (talk | contribs) give the magnitude of the incretin effect as a percentage of the insulin response [rollback]

9 January 2025

  1. (diff | hist) m 23:34 Counterfeit peptide 2,322 +256 VerifyFirstVida (talk | contribs) clarify that a QR code on a certificate proves issuance, not content [rollback]
  2. (diff | hist) m 19:12 Residual solvent 3,607 +727 IncretinIvo (talk | contribs) add the plate-count expression and define its terms [rollback]
  3. (diff | hist) 12:49 Haemoglobin A1c 3,218 ±0 B12_Bettina (talk | contribs) copyedit [rollback]
  4. (diff | hist) m 11:02 Enteroendocrine L cell 4,107 +641 IncretinIvo (talk | contribs) expand §GLP-1 synthesis and secretion [rollback]
  5. (diff | hist) 09:52 Talk:Sangon Biotech 822 +208 NotabilityNoa (talk | contribs) /* Scope: is this a peptide supplier article at all? */ reply
  6. (diff | hist) 09:05 Reverse-phase HPLC 4,246 +362 SecondarySrc_Seb (talk | contribs) add category for method validation [rollback]

8 January 2025

  1. (diff | hist) m 21:15 GLP-1 receptor agonist 8,171 +49 GsCouplingGil (talk | contribs) attribute the mechanism claim to the review rather than stating it flatly [rollback]
  2. (diff | hist) 20:16 Bacterial endotoxin test 4,102 +123 INN_Ingrid (talk | contribs) expand §Methods [rollback]
  3. (diff | hist) 19:42 USP General Chapter 85 2,668 ±0 ChromCleanupCass (talk | contribs) correct the resolution formula — the denominator is the sum of the widths [rollback]
  4. (diff | hist) 14:45 Amino acid analysis 2,621 ±0 ReaderRosalie (talk | contribs) rm the vendor name from a methodological sentence [rollback]
  5. (diff | hist) 14:31 Talk:Sangon Biotech 611 +214 ParentCatPansy (talk | contribs) /* Scope: is this a peptide supplier article at all? */ reply
  6. (diff | hist) m 13:45 Preparative HPLC purification 3,843 +453 RepackRadek (talk | contribs) rm the shipping recommendation — that is advice, not description [rollback]
  7. (diff | hist) 11:20 Regulatory status by jurisdiction 2,721 ±0 UACR_Ulric (talk | contribs) add the customs-detention point with its source [rollback]
  8. (diff | hist) 11:04 Talk:Sangon Biotech 400 +295 ScopeSeverin (talk | contribs) /* Scope: is this a peptide supplier article at all? */ new section
  9. (diff | hist) N 09:00 Global access disparity 1,977 +1,977 DisparityDagny (talk | contribs) new article: access and cost, expansion welcome
  10. (diff | hist) m 08:48 SURMOUNT trial programme 3,270 +133 CommaCarys (talk | contribs) copyedit [rollback]
  11. (diff | hist) m 02:08 LEADER trial 3,178 +45 ReportReaderRilla (talk | contribs) add the discontinuation rate for adverse events in both arms [rollback]

7 January 2025

  1. (diff | hist) 19:25 Personal importation policy 2,232 +42 GMP_Gita (talk | contribs) add the pharmacopoeial chapter reference [rollback]
  2. (diff | hist) m 19:05 Body composition assessment 3,229 ±0 PurityClaimPia (talk | contribs) convert the interval table to include both conventional and SI units [rollback]
  3. (diff | hist) 18:58 Customs seizure 2,364 ±0 BiosimilarBoaz (talk | contribs) expand §Consequences for the material [rollback]
  4. (diff | hist) 17:41 Research use only 6,641 +1,582 SPPS_Sorrel (talk | contribs) copyedit [rollback]
  5. (diff | hist) m 17:19 STEP trial programme 4,064 ±0 Hedgerow_Hal (talk | contribs) expand §Design features that shape the figures [rollback]
  6. (diff | hist) m b 13:01 Cold chain 17,670 +992 ArchiveBot (talk | contribs) bot: update parent category chain [rollback]
  7. (diff | hist) 10:19 Aspiration risk under anaesthesia 3,578 +663 BaselineBex (talk | contribs) British spelling per PP:MOS [rollback]
  8. (diff | hist) m b 08:16 Certificate of analysis 6,396 +363 ArchiveBot (talk | contribs) bot: flag bare reference [rollback]
  9. (diff | hist) m 02:14 Resin cleavage 3,081 +127 RepackRadek (talk | contribs) add category for logistics [rollback]
  10. (diff | hist) m 00:09 Sterile water for injection 3,229 +143 Chromatokid (talk | contribs) state that reconstituted material should not be frozen, with the source [rollback]

6 January 2025

  1. (diff | hist) 18:51 Retention time 3,306 +374 SatietySunniva (talk | contribs) expand §What it can identify [rollback]
  2. (diff | hist) 16:58 Insulin syringe unit conversion 3,086 ±0 RetatrutideRuben (talk | contribs) state that the comparison is across trials and not head-to-head [rollback]
  3. (diff | hist) m 15:49 Nantong Guangyuan Chemical 7,046 +144 AnalyticalAnnie (talk | contribs) de-duplicate a repeated sentence [rollback]
  4. (diff | hist) 13:43 ChinaPeptides 5,511 +185 B12_Bettina (talk | contribs) add the research-use-only statement to the lead rather than only the footer [rollback]
  5. (diff | hist) m 11:23 Underfilling 2,383 ±0 BatchNumberBede (talk | contribs) clarify that agreement between certificate and report is a weak finding [rollback]
  6. (diff | hist) m 10:13 Batch number 3,490 +113 ForestPlotFinn (talk | contribs) expand §Consistency checks [rollback]
  7. (diff | hist) m 10:02 Tianjin Finder Chemical 5,394 +159 PurityClaimPia (talk | contribs) unpipe a link that did not need piping [rollback]
  8. (diff | hist) 08:00 WuXi TIDES 8,541 +950 Chromatokid (talk | contribs) move a stray full stop inside the reference [rollback]
  9. (diff | hist) 07:31 Chinese Peptide Company 8,734 +1,076 CheckSumChase (talk | contribs) copyedit [rollback]
  10. (diff | hist) 06:16 Prior authorisation 1,792 ±0 DisparityDagny (talk | contribs) fix a dangling clause [rollback]
  11. (diff | hist) 05:46 Chain of custody 3,802 +836 EndotoxinEd (talk | contribs) rm the ranking language; this wiki publishes no ranking [rollback]
  12. (diff | hist) 00:32 Insulin secretion 4,555 +109 ArcuateArt (talk | contribs) expand §Pulsatility and measurement [rollback]
  13. (diff | hist) m 00:16 Glucagon 4,913 +26 OrforglipronOona (talk | contribs) add the excipient list from the labelling [rollback]

5 January 2025

  1. (diff | hist) 23:03 Active pharmaceutical ingredient 2,832 +676 ImportRecordIna (talk | contribs) add the citation for the regulatory action [rollback]
  2. (diff | hist) 22:50 Custom peptide synthesis 3,214 +524 FreightFenna (talk | contribs) give the closure integrity test by name [rollback]
  3. (diff | hist) 20:43 Glucagon-like peptide-1 10,017 +73 EmptyingElke (talk | contribs) clarify that concentrations differ substantially between assay platforms [rollback]
  4. (diff | hist) 19:34 Drug master file 2,228 ±0 GreyMarketGreer (talk | contribs) state that the position differs between jurisdictions and give two examples [rollback]
  5. (diff | hist) 18:27 Subcutaneous injection 3,845 +115 GramsNotUnitsGil (talk | contribs) add the disclaimer that this is not administration guidance [rollback]
  6. (diff | hist) 17:26 Triple agonist 3,120 +574 SchematicScout (talk | contribs) the lead claimed weekly dosing for a compound dosed daily; corrected [rollback]
  7. (diff | hist) 17:23 Bachem Holding (Suzhou) 6,093 +201 LotTraceLuka (talk | contribs) British spelling per PP:MOS [rollback]
  8. (diff | hist) 14:42 Sangon Biotech 3,891 +1,443 KarlFischerKit (talk | contribs) add the minimum order quantity for custom synthesis [rollback]
  9. (diff | hist) 14:27 Patent expiry and biosimilars 1,842 ±0 ShortageShona (talk | contribs) add short description [rollback]
  10. (diff | hist) m 09:32 Methionine oxidation 2,680 ±0 TFA_Counterion (talk | contribs) correct the integration description — valley-to-valley, not drop-line [rollback]
  11. (diff | hist) 09:26 Peptide stability table 1,906 +242 SchemaSorcha (talk | contribs) rm the administration advice; the tool computes, it does not instruct [rollback]
  12. (diff | hist) 09:17 Blind sampling 4,821 +892 RegainRomilly (talk | contribs) add the cost basis, since it shapes who submits [rollback]
  13. (diff | hist) m 09:05 MOTS-c 2,609 +558 BPC_Bramwell (talk | contribs) correct the residue numbering — the source numbers from the mature peptide [rollback]
  14. (diff | hist) 01:09 Analytical method validation 4,021 +18 StyleSheetSybil (talk | contribs) add the forced-degradation conditions the claim rests on [rollback]

4 January 2025

  1. (diff | hist) m 22:20 Lot traceability 3,782 +34 GlossaryGleb (talk | contribs) rm the ranking language; this wiki publishes no ranking [rollback]
  2. (diff | hist) 20:49 Vial filling and stoppering 2,773 +25 LiraLotte (talk | contribs) serial comma per PP:MOS [rollback]
  3. (diff | hist) m b 20:05 Liraglutide 4,295 +124 ArchiveBot (talk | contribs) bot: sort category members [rollback]
  4. (diff | hist) 20:03 Oral semaglutide 3,241 +28 INN_Ingrid (talk | contribs) add the structural figure and caption it properly [rollback]
  5. (diff | hist) 17:13 SURPASS trial programme 3,774 ±0 DataTableDunja (talk | contribs) name the funder in the sentence, per PP:MOS [rollback]
  6. (diff | hist) 16:38 Area percent purity 5,314 +245 FreightFenna (talk | contribs) add the reference standard and its traceability [rollback]
  7. (diff | hist) m 14:31 SELECT trial 4,177 +630 SelectTrialSam (talk | contribs) add the comparator arm — an event rate alone says nothing [rollback]
  8. (diff | hist) 13:03 Albumin binding half-life extension 4,401 +45 ChainCustodyChad (talk | contribs) expand §Physical basis [rollback]
  9. (diff | hist) 10:34 USP General Chapter 71 2,254 ±0 NewLabNell (talk | contribs) give the limit of quantitation with the signal-to-noise ratio it assumes [rollback]
  10. (diff | hist) 03:34 Retatrutide 4,597 ±0 ForgeryFinder (talk | contribs) sentence case in headings per PP:MOS [rollback]
  11. (diff | hist) m 01:42 Amylin 3,826 +132 CagriCass (talk | contribs) state plainly that the research-use-only form is not approved for human use [rollback]

3 January 2025

  1. (diff | hist) m b 23:52 Deamidation 3,497 +602 StubSorterBot (talk | contribs) bot: sort category members [rollback]
  2. (diff | hist) m b 22:59 Repackaging 3,558 ±0 CiteBot (talk | contribs) bot: update parent category chain [rollback]
  3. (diff | hist) 22:02 Semaglutide 6,733 +75 NewLabNell (talk | contribs) expand §Pharmacokinetics [rollback]
  4. (diff | hist) 18:27 Number needed to treat 3,207 ±0 SurpassSunniva (talk | contribs) add the run-in period, which changes how the baseline reads [rollback]
  5. (diff | hist) 18:14 Bacteriostatic water 3,577 ±0 EndotoxinEd (talk | contribs) add the note about drawing air before withdrawal [rollback]